What is H.C. Wainwright's price target for AGIO?

H.C. Wainwright's latest stated price target for Agios Pharmaceuticals Inc. (AGIO) is $55, from its action on Oct 29, 2026.

What is H.C. Wainwright's rating on AGIO?

H.C. Wainwright rates AGIO Buy, a bullish rating, as of Oct 29, 2026.

When did H.C. Wainwright last change its view on AGIO?

On Oct 29, 2026, H.C. Wainwright resumes coverage at Buy, price target $55.

Analyst firms · H.C. Wainwright · AGIO

H.C. Wainwright AGIO price target and rating history

Agios Pharmaceuticals Inc. (AGIO) · Health Care

H.C. Wainwright rates Agios Pharmaceuticals Inc. (AGIO) Buy with a $55 price target, as of its latest action on Oct 29, 2026. It has published 8 rating actions on AGIO since July 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a AGIO price target in the last 12 months, the median target is $34. H.C. Wainwright's $55 is 62% above that.

Current rating: Buy
Price target: $55
Median target, all firms: $34
Actions on AGIO: 8

H.C. Wainwright price target on AGIO

H.C. Wainwright price target on AGIO, each point a stated target, July 2021 to October 2026.

Every H.C. Wainwright rating on AGIO

Oct 29, 2026
ResumeH.C. Wainwright resumes coverage at Buy, price target $55
Apr 20, 2026
ReiterateH.C. Wainwright cuts its price target to $50 from $65, keeps Buy
Feb 24, 2025
InitiateH.C. Wainwright starts coverage at Buy, price target $58
Mar 3, 2022
ReiterateH.C. Wainwright cuts its price target to $96 from $98, keeps Buy
Feb 24, 2022
ReiterateH.C. Wainwright cuts its price target to $96 from $98, keeps Buy
Feb 18, 2022
ReiterateH.C. Wainwright raises its price target to $98 from $95, keeps Buy
Nov 4, 2021
ReiterateH.C. Wainwright raises its price target to $95 from $93, keeps Buy
Jul 30, 2021
ReiterateH.C. Wainwright raises its price target to $93 from $88, keeps Buy

How other firms rate AGIO

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Buy	$55	Oct 29, 2026
Truist Securities	Buy		Nov 24, 2025
Leerink Partners	Outperform	$34	Nov 20, 2025
RBC Capital Markets	Sector Perform	$28	Nov 19, 2025

Questions about H.C. Wainwright and AGIO

What is H.C. Wainwright's price target for AGIO?: H.C. Wainwright's latest stated price target for Agios Pharmaceuticals Inc. (AGIO) is $55, from its action on Oct 29, 2026.
What is H.C. Wainwright's rating on AGIO?: H.C. Wainwright rates AGIO Buy, a bullish rating, as of Oct 29, 2026.
When did H.C. Wainwright last change its view on AGIO?: On Oct 29, 2026, H.C. Wainwright resumes coverage at Buy, price target $55.
How does H.C. Wainwright's AGIO target compare with other analysts?: Across 3 firms with a AGIO price target in the last 12 months, the median target is $34. H.C. Wainwright's $55 is 62% above that.

More AGIO rating histories

All H.C. Wainwright ratings AGIO news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.